FMP
NovAccess Global Inc.
XSNX
PNK
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
0.007 USD
-0.001 (-14.29%)
About
ceo
Dr. Dwain K. Morris-Irvin M.P.H., MPH, Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://novaccessglobal.com
exchange
PNK
Description
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
CIK
0001039466
ISIN
US67001N1072
CUSIP
67001N107
Address
8834 Mayfield Road
Phone
440 644 1027
Country
US
Employee
3
IPO Date
Sep 21, 1998
Summary
CIK
0001039466
Exchange
PNK
Industry
Biotechnology
Sector
Healthcare
CUSIP
67001N107
ISIN
US67001N1072
Country
US
Price
0.01
Beta
1.46
Volume Avg.
363.08k
Market Cap
193.72k
Shares
-
52-Week
0.0065-0.22
DCF
0
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.09
P/B
-
Website
https://novaccessglobal.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest XSNX News
It looks like there's no news available.
